Online citations, reference lists, and bibliographies.
← Back to Search

Randomized, Placebo-controlled Evaluation Of Prochlorperazine Versus Metoclopramide For Emergency Department Treatment Of Migraine Headache.

M. Coppola, D. Yealy, R. Leibold
Published 1995 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
STUDY OBJECTIVE To determine the comparative efficacy of i.v. metoclopramide and prochlorperazine for the initial emergency department treatment of migraine headache. DESIGN Prospective, randomized, double-blind, placebo-controlled trial. SETTING Military community hospital ED with an annual census of 75,000. PARTICIPANTS Seventy consenting adults from a convenience sample of patients presenting with migraine headache similar to that experienced in at least one prior episode. Exclusion criteria were pregnancy, fever, signs of meningismus, altered sensorium, drug or alcohol use, oxygen saturation less than 90%, recent trauma or seizure, "worst headache," abnormal blood pressure, recent (within 48 hours) use of metoclopramide or prochlorperazine, and allergy to metoclopramide or prochlorperazine. INTERVENTIONS In a random manner, each subject received a 2-mL i.v. injection of identical-appearing fluid containing metoclopramide (10 mg), prochlorperazine (10 mg), or saline solution (placebo). No other analgesics or medications were administered during the initial study period; rescue agents were administered by the choice of the treating physician after all data were collected. MEASUREMENTS Patients scored their nausea, pain, and sedation before receiving the 2-mL injections and at 30 minutes after injection. Ten-centimeter nonhatched visual analog scales were used for these measurements, with distance from the left end (zero) calculated for each use. Clinically important successful treatment was defined a priori as achievement of the following criteria: patient satisfaction and either a decrease of 50% or more in the 30-minute pain score (compared with the initial score) or an absolute pain score of 2.5 cm or less. Failure to achieve these criteria constituted treatment failure. Differences between groups were analyzed with the Kruskal-Wallis ANOVA and chi 2 tests. Data are reported as frequency percentages and median values, with a two-tailed P value of .05 or less considered significant. RESULTS Nausea, pain, and sedation scores were similar in all three groups before therapy. Thirty minutes after treatment, pain scores differed among those treated with prochlorperazine (1.1 cm), with metoclopramide (3.9 cm), and with placebo (6.1 cm, P = .003). Clinical success occurred more commonly after treatment with prochlorperazine (82%) than after metoclopramide (46%) or placebo (29%, P = .03). However, metoclopramide and placebo scores did not differ (P = .14). Nausea tended to be improved after prochlorperazine, compared with metoclopramide or placebo, at 30 minutes (P = .64). Four patients (6%) returned to the ED for relapse of migraine headache within 24 hours (three in the placebo group and one in the metoclopramide group). CONCLUSION i.v. prochlorperazine relieves the headache and tends to improve nausea better than metoclopramide in ED patients with acute migraine headache.
This paper references
10.1111/J.1365-2125.1975.TB00472.X
The effect of metoclopramide on the absorption of effervescent aspirin in migraine.
G. Volans (1975)
10.1097/00007611-199005000-00011
Neurologic Approach to Drug‐Induced Movement Disorders: A Study of 125 Patients
L. Miller (1990)
10.1111/J.1365-2125.1984.TB05001.X
Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.
R. Tokola (1984)
10.1016/S0196-0644(87)80569-3
Treatment of migraine with intramuscular chlorpromazine.
J. McEwen (1987)
10.1016/S0196-0644(05)81508-2
A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department.
D. Tek (1990)
10.1056/NEJM198001103020221
Addiction rare in patients treated with narcotics.
J. Porter (1980)
10.1016/S0196-0644(83)80251-0
Parenteral chlorpromazine treatment of migraine.
K. Iserson (1983)
10.1111/j.1526-4610.1982.hed2201010.x
Ergotamine vs. Metoclopramide vs. Their Combination in Acute Migraine Attacks
H. Hakkarainen (1982)
10.1046/j.1468-2982.1984.0402107.x
Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study
P. Tfelt-Hansen (1984)
10.1046/j.1468-2982.1984.0404253.x
Tolfenamic Acid, Metoclopramide, Caffeine and Their Combinations in The Treatment of Migraine Attacks
R. Tokola (1984)
10.1016/S0196-0644(05)81507-0
A comparative trial of three agents in the treatment of acute migraine headache.
R. Bell (1990)
10.1016/S0196-0644(05)80201-X
The efficacy of metoclopramide in the treatment of migraine headache.
G. Ellis (1993)
10.1001/JAMA.1989.03420080094038
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache.
J. Jones (1989)
Double-blind controlled study of paramax in the acute treatment of common and classical migraine.
Dexter Sl (1985)
10.2165/00003495-197612020-00001
Metoclopramide: A Review of its Pharmacological Properties and Clinical Use
R. Pinder (2012)
10.1001/JAMA.1961.03040120016004
A survey of drug-induced extrapyramidal reactions.
F. Ayd (1961)
10.1016/S0196-0644(54)00222-3
Intravenous versus rectal prochlorperazine in the treatment of benign vascular or tension headache: a randomized, prospective, double-blind trial.
S. Thomas (1994)



This paper is referenced by
10.1067/MEM.2001.119249
Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial.
R. Collins (2001)
10.1067/MEM.2001.113032
Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial.
D. Vinson (2001)
10.1016/S0149-2918(01)80069-2
Current options for the prevention and treatment of migraine.
J. Adelman (2001)
10.1007/s40272-016-0181-5
Managing Pediatric Pain in the Emergency Department
B. Bailey (2016)
10.1007/978-0-387-88585-8_1
Headache in the Emergency Department
Carrie E. Robertson (2012)
10.1136/EWJM.173.3.189
Migraine: pharmacotherapy in the emergency department.
A. Kelly (2000)
10.1007/s11940-010-0069-6
Treatment of Acute Migraine in the Pediatric Population
H. O’Brien (2010)
10.1067/MEM.2003.24
Variations among emergency departments in the treatment of benign headache.
D. Vinson (2003)
10.1002/JPS.20694
Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation.
J. Rabinowitz (2006)
10.1053/AJEM.2002.35459
Do ED patients with migraine headaches meet internationally accepted criteria?
F. Fiesseler (2002)
10.1111/J.1526-4610.2011.02018.X
Abstracts and Citations: November/December 2011
Stephen H. Landy (2011)
PII: S0304-3959(01)00315-3
Christopher R. Lines (2001)
10.1038/clpt.2008.184
The Pharmacokinetics and Bioavailability of Prochlorperazine Delivered as a Thermally Generated Aerosol in a Single Breath to Volunteers
M. Avram (2009)
10.1111/j.1526-4610.2005.05074.x
Neuroleptics in Headache
H. C. Siow (2005)
10.1111/j.1526-4610.2006.00438.x
Haloperidol in the Acute Treatment of Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
J. Honkaniemi (2006)
10.1046/j.1468-2982.1998.1804174.x
Dopamine and Migraine: A Review of Pharmacological, Biochemical, Neurophysiological, and Therapeutic Data
A. Mascia (1998)
10.1016/S1043-6618(02)00126-3
Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine.
N. Galeotti (2002)
10.1197/AEMJ.9.7.710
The paradox of gold standards.
P. Richman (2002)
10.1001/JAMA.1996.03540190025022
Intranasal lidocaine for treatment of migraine.
C. Sachs (1996)
10.1111/ane.13104
Buccally absorbed vs intravenous prochlorperazine for treatment of migraines headaches
Tasha Fernando (2019)
10.1016/j.ajem.2008.03.044
Slower infusion of metoclopramide decreases the rate of akathisia.
Linda A Regan (2009)
10.1067/MEM.2001.119424
Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.
J. Corbo (2001)
Practice Variation Study Treatment of Children With Migraine in Emergency Departments: National
B. Rowe (2011)
10.1016/J.ANNEMERGMED.2017.07.247
269 The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: ProChlorperazine Versus Ketamine
T. Zitek (2017)
and incidence of akathisia Rate of metoclopramide infusion affects the severity
I. Parlak (2006)
10.1111/j.1742-6723.2009.01179.x
Education initiative improves the evidence‐based use of metoclopramide following morphine administration in the emergency department
Bernard SK Yeoh (2009)
10.1056/JW199511140000002
PROCHLORPERAZINE VS. METOCLOPRAMIDE FOR MIGRAINE.
As Brett (1995)
10.1111/J.1553-2712.2001.TB02111.X
Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial.
M. Blanda (2001)
10.1046/j.1526-4610.2002.02210.x
Efficacy and Tolerability of Prochlorperazine Buccal Tablets in Treatment of Acute Migraine
S. Sharma (2002)
10.1007/S11916-005-0014-7
Management of migraine in children and adolescents in the emergency department and inpatient setting
M. Kabbouche (2005)
10.1016/j.ajem.2014.11.013
Critical reappraisal of intravenous metoclopramide in migraine attack: a systematic review and meta-analysis.
C. Eken (2015)
10.2217/14622416.8.6.609
Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.
F. Fernandez (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar